These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 498152)

  • 1. Nephrotoxicity of cis-dichlorodiammineplatinum(II).
    Krakoff IH
    Cancer Treat Rep; 1979; 63(9-10):1523-5. PubMed ID: 498152
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of mannitol or furosemide diuresis on the nephrotoxicity and physiological disposition of cis-dichlorodiammineplatinum-(II) in rats.
    Pera MF; Zook BC; Harder HC
    Cancer Res; 1979 Apr; 39(4):1269-78. PubMed ID: 421210
    [No Abstract]   [Full Text] [Related]  

  • 3. Cisplatin nephrotoxicity: experimental and clinical studies.
    Daugaard G
    Dan Med Bull; 1990 Feb; 37(1):1-12. PubMed ID: 2178884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amelioration of cisplatin-induced ototoxicity by fosfomycin.
    Schweitzer VG; Dolan DF; Abrams GE; Davidson T; Snyder R
    Laryngoscope; 1986 Sep; 96(9 Pt 1):948-58. PubMed ID: 3747696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective inhibition of the nephrotoxicity of cis-dichlorodiammineplatinum(II) by WR-2721 without altering its antitumor properties.
    Yuhas JM; Culo F
    Cancer Treat Rep; 1980 Jan; 64(1):57-64. PubMed ID: 6247064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of cisplatin nephrotoxicity.
    Weiner MW; Jacobs C
    Fed Proc; 1983 Oct; 42(13):2974-8. PubMed ID: 6684595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Nephrotoxicity mechanisms of the antitumor preparation, cis-dichlorodiammineplatinum].
    Belkin AL; Sidorik OA; Pendrak KA; Povzhitkova MS; Osadchaia LP
    Vopr Onkol; 1979; 25(8):95-6. PubMed ID: 483710
    [No Abstract]   [Full Text] [Related]  

  • 8. Minireview. The nephrotoxicity of cisplatin.
    Goldstein RS; Mayor GH
    Life Sci; 1983 Feb; 32(7):685-90. PubMed ID: 6338333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute and chronic cisplatin nephropathy in rats.
    Choie DD; Longnecker DS; del Campo AA
    Lab Invest; 1981 May; 44(5):397-402. PubMed ID: 7194946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The renal pathology in clinical trials of cis-platinum (II) diamminedichloride.
    Gonzales-Vitale JC; Hayes DM; Cvitkovic E; Sternberg SS
    Cancer; 1977 Apr; 39(4):1362-71. PubMed ID: 851939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of nifedipine on cisplatinum-induced nephrotoxicity in rats.
    Deray G; Dubois M; Beaufils H; Cacoub P; Anouar M; Jaudon MC; Baumelou A; Jouanneau C; Jacobs C
    Clin Nephrol; 1988 Sep; 30(3):146-50. PubMed ID: 3180522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safe, rapid administration schedule for cis-platinum-mannitol.
    Rainey JM; Alberts DS
    Med Pediatr Oncol; 1978; 4(4):371-5. PubMed ID: 723800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. cis-Dichlorodiammineplatinum(II) in non-small cell carcinoma of the lung.
    Gralla RJ; Cvitkovic E; Golbey RB
    Cancer Treat Rep; 1979; 63(9-10):1585-8. PubMed ID: 498158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the possible role of iron and copper in cisplatin-induced nephrotoxicity in the rat.
    Goudie J; Chandra M; Lawrence GD; Williams P
    Res Commun Chem Pathol Pharmacol; 1994 Jan; 83(1):33-49. PubMed ID: 8165368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement of cis-dichlorodiammineplatinum (NSC 119875): therapeutic index in an animal model.
    Cvitkovic E; Spaulding J; Bethune V; Martin J; Whitmore WF
    Cancer; 1977 Apr; 39(4):1357-61. PubMed ID: 856436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cisplatin nephrotoxicity is mediated by gamma glutamyltranspeptidase, not via a C-S lyase governed biotransformation pathway.
    Wainford RD; Weaver RJ; Stewart KN; Brown P; Hawksworth GM
    Toxicology; 2008 Jul; 249(2-3):184-93. PubMed ID: 18583013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modification of the renal toxicity of cis-dichlorodiammineplatinum(II) with furosemide in male F344 rats.
    Ward JM; Grabin ME; LeRoy AF; Young DM
    Cancer Treat Rep; 1977; 61(3):375-9. PubMed ID: 872137
    [No Abstract]   [Full Text] [Related]  

  • 18. A pathophysiologic role for T lymphocytes in murine acute cisplatin nephrotoxicity.
    Liu M; Chien CC; Burne-Taney M; Molls RR; Racusen LC; Colvin RB; Rabb H
    J Am Soc Nephrol; 2006 Mar; 17(3):765-74. PubMed ID: 16481417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effect of organic cation transport inhibitors on cis-diamminedichloroplatinum-induced nephrotoxicity.
    Bird JE; Walser MM; Quebbemann AJ
    J Pharmacol Exp Ther; 1984 Dec; 231(3):752-8. PubMed ID: 6542140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. cis-diamminedichloroplatinum(II) nephrotoxicity: tubular function after rescue with sodium diethyldithiocarbamate in rats.
    Elliott WC; Newcom SR; Houghton DC; Baines-Hunter J; Bennett WM
    Cancer Res; 1983 Aug; 43(8):3759-62. PubMed ID: 6305493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.